Valuation: Terumo Corporation

Market Cap 3,244B 19.88B 17.43B 16.2B 14.88B 28B 1,920B 28.46B 191B 75.25B 939B 74.65B 73.05B P/E 2027 *
19.4x
P/E 2028 * 17.4x
Enterprise Value 3,319B 20.34B 17.84B 16.57B 15.22B 28.65B 1,965B 29.12B 196B 77.01B 961B 76.39B 74.76B EV / Sales 2027 *
2.68x
EV / Sales 2028 * 2.47x
Free-Float
97.07%
Yield 2027 *
1.62%
Yield 2028 * 1.81%
Manager TitleAgeSince
Chief Executive Officer 62 2024-03-31
Director of Finance/CFO - -
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 68 2022-03-31
Director/Board Member 63 2019-06-20
Director/Board Member 75 2020-06-24
Change 5-day change 1-year change 3-year change Capi.($)
+1.19%+3.03% - - 20.28B
+0.90%+13.05%-19.17%-12.00% 174B
-0.56%+3.27%-8.71%-7.95% 105B
-0.82%-0.56%+2.70%+56.07% 58.97B
-1.59%-2.05%+36.71%+59.47% 52.24B
-0.44%+1.67%-12.64%-42.17% 42.39B
-4.89%-3.83% - - 33.05B
-4.44%-3.63%-14.99%-45.31% 28.84B
-0.23%+0.21%+70.61%-5.01% 25.38B
-0.56%+0.88%-5.43%-9.27% 20.64B
Average -1.10%+2.41%+6.13%-0.77% 60.06B
Weighted average by Cap. -0.52%+4.96%-2.87%+0.15%

Financials

2027 *2028 *
Net sales 1,239B 7.59B 6.65B 6.18B 5.68B 10.69B 733B 10.87B 73.05B 28.73B 358B 28.5B 27.89B 1,317B 8.07B 7.08B 6.58B 6.04B 11.37B 780B 11.56B 77.69B 30.56B 381B 30.32B 29.67B
Net income 166B 1.02B 891M 828M 760M 1.43B 98.1B 1.45B 9.78B 3.85B 47.97B 3.81B 3.73B 185B 1.14B 996M 926M 850M 1.6B 110B 1.63B 10.94B 4.3B 53.67B 4.27B 4.18B
Net Debt 75.69B 464M 407M 378M 347M 653M 44.79B 664M 4.46B 1.76B 21.9B 1.74B 1.7B 14.29B 87.57M 76.78M 71.35M 65.53M 123M 8.46B 125M 843M 332M 4.14B 329M 322M
Logo Terumo Corporation
Terumo Corp is a Japan-based company mainly engaged in the manufacture and sale of medical devices and pharmaceuticals. The Company operates in three segments. The Cardiovascular Company segment provides guidewires for angiography, catheters for angiography, introducer sheaths, coils, stents and bag embolization devices for treatment of cerebral aneurysms, artificial lungs and artificial heart-lung machines. The Medical Care Solutions Company segment provides hospital care solutions, life care solutions, and pharmaceutical solutions. The Blood and Cell Technology Company segment provides blood bags, component blood collection systems, automated blood product systems, pathogen reduction systems, and centrifugal blood component separators.
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
-